Concepedia

Author

Gabriela Kornek

Medical University of Vienna

Also Known As

G Kornek, G V Kornek, G Verena Kornek, G. KORNEK, G. Kornek, G. V. Kornek, G.  Kornek, G.V Kornek, G.V. Kornek, GABRIELA KORNEK

221

Publications

8.7K

Citations

43

H-Index

85

Concepts

All Affiliations

Medical University of ViennaUniversity of ViennaVienna General HospitalFachhochschule Wiener NeustadtÖsterreichische Gesellschaft für Hypertensiologie
GK

About

Gabriela Kornek is an author at Medical University of Vienna specializing in oncology, medicine, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

26

59

2.8K

2

Health Sciences

13

14

373

3

Nursing

1

1

21

4

Public Health

1

1

21

5

Anatomy

1

1

18

Gabriela Kornek

×

115

Publications

7.5K

Citations

40

H-Index

YearCitations

Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer.

Werner Scheithauer, Harald Rosén, Gabriela Kornek,

BMJ

1993

658

Gemcitabine Plus Capecitabine Compared With Gemcitabine Alone in Advanced Pancreatic Cancer: A Randomized, Multicenter, Phase III Trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group

Richard Herrmann, G. Bodoky, Thomas Ruhstaller,

Journal of Clinical Oncology

2007

590

High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)

Cihan Ay, Ralph Simanek, Rainer Vormittag,

Blood

2008

415

Paul Ehrlich (1854-1915) and His Contributions to the Foundation and Birth of Translational Medicine

Peter Valent, Bernd Groner, Udo Schumacher,

Journal of Innate Immunity

2016

403

Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality

Noémi Pávó, Markus Raderer, Martin Hülsmann,

Heart

2015

267

Microparticle‐associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients

J. Thaler, Cihan Ay, Nigel Mackman,

Journal of Thrombosis and Haemostasis

2012

266

Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx

Christoph Glaser, W. Millesi, Gabriela Kornek,

International Journal of Radiation Oncology*Biology*Physics

2001

262

Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck

J. Bernier, James A. Bonner, Jan B. Vermorken,

Annals of Oncology

2007

217

Biweekly high-dose gemcitabine alone or in combination with capecitabine in patients with metastatic pancreatic adenocarcinoma: a randomized phase II trial

Werner Scheithauer, B. Schüll, H. Ulrich-Pur,

Annals of Oncology

2002

187

Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer

M. Penz, Gabriela Kornek, Markus Raderer,

Annals of Oncology

2001

176

Page 1